Schedule 13G ownership disclosure
Axsome Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 05464T104
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LP
Shares: 1,516,903.00 · Class: 3.1%
- Roderick Wong
Shares: 1,516,903.00 · Class: 3.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021702
- Form type
- SCHEDULE 13G/A
- Filer
- Axsome Therapeutics, Inc.
- CIK
- CIK 1579428
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership